[99mTc]Diphosphonate uptake and hemodynamics in experimental arthritis: Effect of naproxen in the canine carrageenan injection model

✍ Scribed by Dr. Ebbe Stender Hansen; Shu-Zheng He; Kjeld Søballe; Dorthe Kjølseth; Tine Brink Henriksen; Vibeke Elisabeth Hjortdal; Cody Bünger

• Publisher: Elsevier Science
• Year: 1992
• Tongue: English
• Weight: 895 KB
• Volume: 10
• Category: Article
• ISSN: 0736-0266
• DOI: 10.1002/jor.1100100507

✦ Synopsis

Abstract

The impact of naproxen treatment on juxta‐articular hemodynamics and bone metabolism in experimental juvenile arthritis was studied in the articular carrageenan injection model. Unilateral gonarthritis was induced for 12 weeks in eight dogs receiving naproxen (dosage, 2 mg/kg) and eight controls. Regional blood flow was assessed by the microsphere method, plasma volume by the distribution space of [^125^I]fibrinogen, and bone metabolism by the 2‐h uptake of [^99m^Tc]diphosphonate ([^99m^Tc]DPD). Synovial effusion was less prominent with naproxen treatment as judged by joint fluid volume and pressure. Naproxen reduced the arthritic capsular hyperemia, almost normalized a severe blood flow increase in patella and both juxta‐articular epiphyses, ameliorated an expansion of plasma volume in the patella and the distal femoral epiphysis, and normalized an increased [^99m^Tc]DPD uptake in subchondral femoral bone and the tibial cortex. Significantly increased arteriovenous shunting in the arthritic extremity was unaffected by naproxen. The study suggests that long‐term cyclooxygenase inhibition offers protection against hemodynamic and metabolic changes in juxta‐articular bone secondary to synovial inflammation.